Oktober 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) har blitt godkjent av Food and Drug Administration for voksne og pediatriske pasienter 12 år og eldre som har lokalt avansert eller metastatisk differensiert skjoldbruskkjertel.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..